JP2010524912A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010524912A5 JP2010524912A5 JP2010503587A JP2010503587A JP2010524912A5 JP 2010524912 A5 JP2010524912 A5 JP 2010524912A5 JP 2010503587 A JP2010503587 A JP 2010503587A JP 2010503587 A JP2010503587 A JP 2010503587A JP 2010524912 A5 JP2010524912 A5 JP 2010524912A5
- Authority
- JP
- Japan
- Prior art keywords
- cannabinoid
- use according
- containing plant
- plant extracts
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229930003827 cannabinoid Natural products 0.000 claims 24
- 239000003557 cannabinoid Substances 0.000 claims 24
- 239000000419 plant extract Substances 0.000 claims 17
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 claims 5
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 claims 5
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 claims 5
- 229950011318 cannabidiol Drugs 0.000 claims 5
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 claims 5
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims 5
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 claims 5
- 229960004242 dronabinol Drugs 0.000 claims 5
- 241000218236 Cannabis Species 0.000 claims 4
- 239000002552 dosage form Substances 0.000 claims 3
- 239000000284 extract Substances 0.000 claims 3
- UVOLYTDXHDXWJU-UHFFFAOYSA-N Cannabichromene Chemical compound C1=CC(C)(CCC=C(C)C)OC2=CC(CCCCC)=CC(O)=C21 UVOLYTDXHDXWJU-UHFFFAOYSA-N 0.000 claims 2
- 102000003610 TRPM8 Human genes 0.000 claims 2
- 101150111302 Trpm8 gene Proteins 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- QXACEHWTBCFNSA-SFQUDFHCSA-N cannabigerol Chemical compound CCCCCC1=CC(O)=C(C\C=C(/C)CCC=C(C)C)C(O)=C1 QXACEHWTBCFNSA-SFQUDFHCSA-N 0.000 claims 2
- 239000000499 gel Substances 0.000 claims 2
- 206010006187 Breast cancer Diseases 0.000 claims 1
- 208000026310 Breast neoplasm Diseases 0.000 claims 1
- UVOLYTDXHDXWJU-NRFANRHFSA-N Cannabichromene Natural products C1=C[C@](C)(CCC=C(C)C)OC2=CC(CCCCC)=CC(O)=C21 UVOLYTDXHDXWJU-NRFANRHFSA-N 0.000 claims 1
- 206010009944 Colon cancer Diseases 0.000 claims 1
- ORKZJYDOERTGKY-UHFFFAOYSA-N Dihydrocannabichromen Natural products C1CC(C)(CCC=C(C)C)OC2=CC(CCCCC)=CC(O)=C21 ORKZJYDOERTGKY-UHFFFAOYSA-N 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 206010060862 Prostate cancer Diseases 0.000 claims 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims 1
- 208000000453 Skin Neoplasms Diseases 0.000 claims 1
- 239000005557 antagonist Substances 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- WVOLTBSCXRRQFR-DLBZAZTESA-N cannabidiolic acid Chemical compound OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-DLBZAZTESA-N 0.000 claims 1
- QXACEHWTBCFNSA-UHFFFAOYSA-N cannabigerol Natural products CCCCCC1=CC(O)=C(CC=C(C)CCC=C(C)C)C(O)=C1 QXACEHWTBCFNSA-UHFFFAOYSA-N 0.000 claims 1
- 229940065144 cannabinoids Drugs 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 208000029742 colonic neoplasm Diseases 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 230000002685 pulmonary effect Effects 0.000 claims 1
- 201000000849 skin cancer Diseases 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 230000004083 survival effect Effects 0.000 claims 1
- 238000009834 vaporization Methods 0.000 claims 1
- 230000008016 vaporization Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0707610.2 | 2007-04-19 | ||
| GB0707610A GB2448535A (en) | 2007-04-19 | 2007-04-19 | New use for cannabinoid-containing plant extracts |
| PCT/GB2008/001359 WO2008129258A1 (en) | 2007-04-19 | 2008-04-17 | New use for cannabinoid-containing plant extracts |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010524912A JP2010524912A (ja) | 2010-07-22 |
| JP2010524912A5 true JP2010524912A5 (enExample) | 2011-03-10 |
| JP5775300B2 JP5775300B2 (ja) | 2015-09-09 |
Family
ID=38135105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010503587A Active JP5775300B2 (ja) | 2007-04-19 | 2008-04-17 | カンナビノイド含有植物抽出物の新規な用途 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20100249223A1 (enExample) |
| EP (1) | EP2146731B1 (enExample) |
| JP (1) | JP5775300B2 (enExample) |
| CN (1) | CN101678059A (enExample) |
| CA (1) | CA2684562A1 (enExample) |
| ES (1) | ES2717839T3 (enExample) |
| GB (1) | GB2448535A (enExample) |
| WO (1) | WO2008129258A1 (enExample) |
Families Citing this family (87)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008013861A2 (en) | 2006-07-27 | 2008-01-31 | Redpoint Bio Corporation | Screening assay for inhibitors of trpa1 activation by a lower alkyl phenol |
| US9084771B2 (en) | 2007-05-17 | 2015-07-21 | Sutter West Bay Hospitals | Methods and compositions for treating cancer |
| GB2471987B (en) * | 2008-06-04 | 2012-02-22 | Gw Pharma Ltd | Anti-tumoural effects of cannabinoid combinations |
| KR101063352B1 (ko) | 2008-11-28 | 2011-09-07 | 고려대학교 산학협력단 | Ｔｒｐａ１ 활성 억제 약물 및 이의 활용 |
| DE102010002558A1 (de) | 2009-11-20 | 2011-06-01 | Symrise Ag | Verwendung physiologischer Kühlwirkstoffe und Mittel enthaltend solche Wirkstoffe |
| GB2478595B (en) * | 2010-03-12 | 2018-04-04 | Gw Pharma Ltd | Phytocannabinoids in the treatment of glioma |
| TWI583374B (zh) | 2010-03-30 | 2017-05-21 | Ｇｗ伐瑪有限公司 | 使用植物大麻素次大麻二酚（ｃｂｄｖ）來治療癲癇之用途 |
| US8445034B1 (en) | 2010-11-02 | 2013-05-21 | Albert L Coles, Jr. | Systems and methods for producing organic cannabis tincture |
| GB2487712B (en) | 2011-01-04 | 2015-10-28 | Otsuka Pharma Co Ltd | Use of the phytocannabinoid cannabidiol (CBD) in combination with a standard anti-epileptic drug (SAED) in the treatment of epilepsy |
| JP6061448B2 (ja) * | 2011-03-10 | 2017-01-18 | 株式会社マンダム | 被験物質の評価方法 |
| KR20120111125A (ko) * | 2011-03-31 | 2012-10-10 | 주식회사한국전통의학연구소 | 마자인 추출물을 포함하는 신장암 치료용 조성물 및 건강 기능성 식품 |
| GB2524689B (en) | 2011-05-20 | 2016-01-27 | Gw Pharma Ltd | Cannabinoids for use in the treatment of neuropathic pain |
| GB2494461A (en) | 2011-09-12 | 2013-03-13 | Gw Pharma Ltd | Phytocannabinoids for use in the treatment of invasive cancers or metastases |
| GB2495118B (en) | 2011-09-29 | 2016-05-18 | Otsuka Pharma Co Ltd | A pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD) |
| GB201117956D0 (en) * | 2011-10-18 | 2011-11-30 | Otsuka Pharma Co Ltd | Phytocannabinoids for use in the treatment of breast cancer |
| US9776014B2 (en) | 2012-05-03 | 2017-10-03 | Magdent Ltd. | Bone enhancement device and method |
| NL2009671C2 (en) * | 2012-10-19 | 2014-04-23 | Fytagoras B V | New antiviral use for acidic cannabinoids. |
| GB2516814B (en) | 2013-06-19 | 2016-08-31 | Otsuka Pharma Co Ltd | Use of phytocannabinoids for increasing radiosensitivity in the treatment of cancer |
| US10774288B2 (en) | 2013-09-18 | 2020-09-15 | The Werc Shop, LLC | Terpene-based compositions, processes, methodologies for creation and products thereby |
| US9220294B2 (en) | 2014-02-11 | 2015-12-29 | Timothy McCullough | Methods and devices using cannabis vapors |
| US10821240B2 (en) | 2014-02-11 | 2020-11-03 | Vapor Cartridge Technology Llc | Methods and drug delivery devices using cannabis |
| US9380813B2 (en) | 2014-02-11 | 2016-07-05 | Timothy McCullough | Drug delivery system and method |
| JP6673895B2 (ja) | 2014-03-21 | 2020-03-25 | エスティー アンド ティー インターナショナル，インコーポレイティド | アサ属抽出方法及び組成物 |
| US9044390B1 (en) | 2014-04-17 | 2015-06-02 | Gary J. Speier | Pharmaceutical composition and method of manufacturing |
| US9186386B2 (en) | 2014-04-17 | 2015-11-17 | Gary J. Speier | Pharmaceutical composition and method of manufacturing |
| GB2530001B (en) | 2014-06-17 | 2019-01-16 | Gw Pharma Ltd | Use of cannabidiol in the reduction of convulsive seizure frequency in treatment-resistant epilepsy |
| GB2527599A (en) | 2014-06-27 | 2015-12-30 | Gw Pharma Ltd | Use of 7-OH-Cannabidiol (7-OH-CBD) and/or 7-OH-Cannabidivarin (7-OH-CBDV) in the treatment of epilepsy |
| GB2527590A (en) * | 2014-06-27 | 2015-12-30 | Otsuka Pharma Co Ltd | Active pharmaceutical ingredient (API) comprising cannabinoids for use in the treatment of cancer |
| CN105477635A (zh) * | 2014-09-15 | 2016-04-13 | 中国人民解放军第二军医大学 | 一种治疗持续性慢性疼痛的靶点和药物 |
| GB2531282A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabinoids in the treatment of epilepsy |
| GB2531278A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabidiol in the treatment of intractable epilepsy |
| GB2531281A (en) | 2014-10-14 | 2016-04-20 | Gw Pharma Ltd | Use of cannabidiol in the treatment of intractable epilepsy |
| BR122021018502B1 (pt) | 2014-10-21 | 2022-05-03 | United Cannabis Corp | Formulação de canabinoide líquida |
| WO2016123475A1 (en) | 2015-01-31 | 2016-08-04 | Constance Therapeutics, Inc. | Methods for preparation of cannabis oil extracts and compositions |
| US10238745B2 (en) | 2015-01-31 | 2019-03-26 | Constance Therapeutics, Inc. | Cannabinoid composition and products including α-tocopherol |
| MX2017010872A (es) | 2015-02-27 | 2018-05-07 | Ebbu Llc | Composiciones que comprenden combinaciones de cannabinoides purificados, con al menos uno de flavonoides, terpenos o minerales. |
| US10960035B2 (en) | 2015-04-01 | 2021-03-30 | The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Voleaui Center) | Erodium crassifolium L'Her plant extracts and uses thereof |
| US12303541B2 (en) | 2015-04-01 | 2025-05-20 | The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center) | Erodium crassifolium L'Her plant extracts and uses thereof |
| GB2539472A (en) | 2015-06-17 | 2016-12-21 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| WO2017013661A1 (en) | 2015-07-22 | 2017-01-26 | Phytopharma International Ltd. | Bee-ingestible compositions, methods of using same for producing honey and honey produced thereby |
| GB2541191A (en) | 2015-08-10 | 2017-02-15 | Gw Pharma Ltd | Use of cannabinoids in the treatment of epilepsy |
| GB2542797A (en) * | 2015-09-29 | 2017-04-05 | Gw Pharma Ltd | Use of cannabinoids in the treatment of inflammatory skin diseases |
| WO2017059088A1 (en) * | 2015-09-30 | 2017-04-06 | George Edward Hoag | Topical analgesic pain relife formulations, manufacture and methods of use thereof |
| WO2017091764A1 (en) | 2015-11-24 | 2017-06-01 | Constance Therapeutics, Inc. | Cannabis oil compositions and methods for preparation thereof |
| GB2548873B (en) | 2016-03-31 | 2020-12-02 | Gw Res Ltd | Use of Cannabidiol in the Treatment of SturgeWeber Syndrome |
| US10499584B2 (en) | 2016-05-27 | 2019-12-10 | New West Genetics | Industrial hemp Cannabis cultivars and seeds with stable cannabinoid profiles |
| EP3471745B1 (en) * | 2016-06-15 | 2025-03-26 | Ojai Energetics PBC | Compositions for reducing oxidative stress |
| US10143706B2 (en) | 2016-06-29 | 2018-12-04 | Cannscience Innovations, Inc. | Decarboxylated cannabis resins, uses thereof and methods of making same |
| GB2551987A (en) | 2016-07-01 | 2018-01-10 | Gw Res Ltd | Oral cannabinoid formulations |
| GB2551986A (en) | 2016-07-01 | 2018-01-10 | Gw Res Ltd | Parenteral formulations |
| GB2553139A (en) | 2016-08-25 | 2018-02-28 | Gw Res Ltd | Use of cannabinoids in the treatment of multiple myeloma |
| US12485129B2 (en) | 2016-08-29 | 2025-12-02 | Canopy Growth Corporation | Water soluble compositions comprising purified cannabinoids |
| CN110177543A (zh) | 2016-08-29 | 2019-08-27 | 凯诺比生长公司 | 包含纯化大麻素的水溶性组合物 |
| IL265902B2 (en) * | 2016-10-11 | 2024-04-01 | Gbs Global Biopharma Inc | Cannabinoid-containing complex mixtures for the treatment of neurodegenerative diseases |
| US10239808B1 (en) | 2016-12-07 | 2019-03-26 | Canopy Holdings, LLC | Cannabis extracts |
| GB2557921A (en) | 2016-12-16 | 2018-07-04 | Gw Res Ltd | Use of cannabinoids in the treatment of angelman syndrome |
| GB2559774B (en) | 2017-02-17 | 2021-09-29 | Gw Res Ltd | Oral cannabinoid formulations |
| GB2560019A (en) | 2017-02-27 | 2018-08-29 | Gw Res Ltd | Use of cannabinoids in the treatment of leukaemia |
| IL269158B2 (en) | 2017-03-05 | 2024-04-01 | The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro Vo | Cannabis compositions enriched in thca and their use in treating inflammatory diseases |
| AU2018273194B2 (en) | 2017-05-22 | 2023-05-25 | Gbs Global Biopharma, Inc. | Myrcene- and cannabinoid-containing compositions which target TRPV1 |
| GB2564383B (en) | 2017-06-23 | 2021-04-21 | Gw Res Ltd | Use of cannabidiol in the treatment of tumours assoicated with Tuberous Sclerosis Complex |
| EP3675809B1 (de) | 2017-08-31 | 2023-09-27 | Basf Se | Verwendung physiologischer kühlwirkstoffe und mittel enthaltend solche wirkstoffe |
| GB2568929A (en) | 2017-12-01 | 2019-06-05 | Gw Res Ltd | Use of cannabinoids in the treatment of epilepsy |
| CN109939014A (zh) * | 2017-12-20 | 2019-06-28 | 汉义生物科技（北京）有限公司 | 一种含有大麻素的口气清新剂 |
| GB2569961B (en) | 2018-01-03 | 2021-12-22 | Gw Res Ltd | Pharmaceutical |
| EP3745884A1 (en) | 2018-01-31 | 2020-12-09 | Canopy Holdings, Llc | Hemp powder |
| JP2021521277A (ja) | 2018-04-09 | 2021-08-26 | エレヴェット・サイエンシズ | 動物における疼痛の処置のためのアサ抽出物 |
| WO2019222459A1 (en) * | 2018-05-18 | 2019-11-21 | Diverse Biotech, Inc. | Cannabinoid preparations and therapeutic uses |
| JP2021524465A (ja) * | 2018-05-22 | 2021-09-13 | ジービーエス グローバル バイオファーマ，インコーポレイテッド | Ｔｒｐｖ１モジュレーションに使用するためのカンナビノイド及び／又はテルペン |
| CA3104795A1 (en) * | 2018-06-28 | 2020-01-02 | Canopy Growth Corporation | Compositions and methods for agonizing the cb2 receptor |
| US11040932B2 (en) | 2018-10-10 | 2021-06-22 | Treehouse Biotech, Inc. | Synthesis of cannabigerol |
| EP3968970A4 (en) * | 2019-05-16 | 2023-01-25 | Buzzelet Development And Technologies Ltd | Local anesthetic comprising a trp channel modulator |
| WO2021055079A1 (en) | 2019-09-16 | 2021-03-25 | Vapor Cartridge Technology Llc | Drug delivery system with stackable substrates |
| CN112569220B (zh) * | 2019-09-30 | 2023-03-07 | 云南汉盟制药有限公司 | 四氢次大麻酚在制备用于治疗肺动脉高压药物中的应用及含有四氢次大麻酚的药物组合物 |
| US12409131B2 (en) | 2019-10-03 | 2025-09-09 | Pike Therapeutics Usa, Inc. | Transdermal delivery of dronabinol |
| US20210100737A1 (en) | 2019-10-03 | 2021-04-08 | Starton Therapeutics, Inc. | Transdermal delivery of dronabinol |
| US12016829B2 (en) | 2019-10-11 | 2024-06-25 | Pike Therapeutics Inc. | Pharmaceutical composition and method for treating seizure disorders |
| WO2021070120A1 (en) | 2019-10-11 | 2021-04-15 | Pike Therapeutics, Inc., 1219014 B.C. Ltd. | Transdermal compositions comprising cannabidiol (cbd) for use in the treatment of seizure disorders |
| US12121617B2 (en) | 2019-10-14 | 2024-10-22 | Pike Therapeutics Inc. | Transdermal delivery of cannabidiol |
| JP2022551730A (ja) | 2019-10-14 | 2022-12-13 | パイク セラピューティクス，インコーポレイテッド | カンナビジオールの経皮送達 |
| GB202002754D0 (en) | 2020-02-27 | 2020-04-15 | Gw Res Ltd | Methods of treating tuberous sclerosis complex with cannabidiol and everolimus |
| WO2021188983A1 (en) * | 2020-03-20 | 2021-09-23 | The Queen's Medical Center | Cannabinoid compositions |
| IL297546A (en) * | 2020-04-24 | 2022-12-01 | Zyus Life Sciences Inc | Cannabichromene formulation for pain management |
| KR102433007B1 (ko) * | 2020-07-28 | 2022-08-16 | 동의대학교 산학협력단 | 산골취 추출물을 포함하는 신경병증성 통증 예방 및 개선용 조성물 |
| US11160757B1 (en) | 2020-10-12 | 2021-11-02 | GW Research Limited | pH dependent release coated microparticle cannabinoid formulations |
| US12440454B2 (en) | 2022-02-01 | 2025-10-14 | Portland Technology Holdings Llc | Pharmaceutical compositions containing hemp extract for administration to felines and related methods |
| CN119912407A (zh) * | 2023-10-31 | 2025-05-02 | 北京红惠新医药科技有限公司 | 大麻二酚环氧化物的制备方法及应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4837228A (en) * | 1979-05-31 | 1989-06-06 | The University Of Mississippi | Antiinflammatory and antimicrobial compounds and compositions |
| JPH0426622A (ja) * | 1990-05-18 | 1992-01-29 | Tsumura & Co | 制癌剤 |
| US5939429A (en) * | 1997-09-30 | 1999-08-17 | Virginia Commonwealth University | Cardiovascular uses of cannabinoid compounds |
| GB9807639D0 (en) * | 1998-04-14 | 1998-06-10 | Kennedy Rheumatology Inst | Anti-inflammatory agents |
| US6403126B1 (en) * | 1999-05-26 | 2002-06-11 | Websar Innovations Inc. | Cannabinoid extraction method |
| US6949582B1 (en) * | 1999-05-27 | 2005-09-27 | Wallace Walter H | Method of relieving analgesia and reducing inflamation using a cannabinoid delivery topical liniment |
| EP2298284A3 (en) * | 2001-02-14 | 2013-12-18 | GW Pharma Limited | Mucoadhesive pharmaceutical formulations |
| US7025992B2 (en) * | 2001-02-14 | 2006-04-11 | Gw Pharma Limited | Pharmaceutical formulations |
| GB2377633A (en) * | 2001-05-11 | 2003-01-22 | Gw Pharmaceuticals Ltd | Pharmaceutical compositions comprising the cannabinoids THC and CBD |
| CH695661A5 (de) * | 2001-03-06 | 2006-07-31 | Forsch Hiscia Ver Fuer Krebsfo | Pharmazeutische Zusammensetzung. |
| EP1497328A2 (en) * | 2002-04-16 | 2005-01-19 | Bayer HealthCare AG | Regulation of human transient receptor potential channel |
| GB2394894B (en) * | 2002-11-04 | 2005-08-31 | G W Pharma Ltd | New use for pharmaceutical composition |
| GB2414933B (en) * | 2004-06-08 | 2009-07-15 | Gw Pharma Ltd | Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis |
| GB2418612A (en) * | 2004-10-01 | 2006-04-05 | Gw Pharma Ltd | Inhibition of tumour cell migration with cannabinoids |
| US7597910B2 (en) * | 2005-08-20 | 2009-10-06 | Slgm Medical Research Institute | Compositions and methods for treating prostate disorders |
| JP2009513159A (ja) * | 2005-10-31 | 2009-04-02 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Ｔｒｐｖ２のモジュレーターを同定するための組成物および方法 |
| GB2432312A (en) * | 2005-11-01 | 2007-05-23 | Gw Pharma Ltd | Pharmaceutical compositions for the treatment of pain |
-
2007
- 2007-04-19 GB GB0707610A patent/GB2448535A/en not_active Withdrawn
-
2008
- 2008-04-17 WO PCT/GB2008/001359 patent/WO2008129258A1/en not_active Ceased
- 2008-04-17 ES ES08737019T patent/ES2717839T3/es active Active
- 2008-04-17 EP EP08737019.3A patent/EP2146731B1/en active Active
- 2008-04-17 CA CA002684562A patent/CA2684562A1/en not_active Abandoned
- 2008-04-17 US US12/596,500 patent/US20100249223A1/en not_active Abandoned
- 2008-04-17 JP JP2010503587A patent/JP5775300B2/ja active Active
- 2008-04-17 CN CN200880016574A patent/CN101678059A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010524912A5 (enExample) | ||
| Talib et al. | Combination anticancer therapies using selected phytochemicals | |
| Chojnacka et al. | Phytochemicals containing biologically active polyphenols as an effective agent against Covid-19-inducing coronavirus | |
| Zhang et al. | The combinatory effects of natural products and chemotherapy drugs and their mechanisms in breast cancer treatment | |
| Baron | Medicinal properties of cannabinoids, terpenes, and flavonoids in cannabis, and benefits in migraine, headache, and pain: an update on current evidence and cannabis science | |
| Ko et al. | Flavonoids as therapeutic candidates for emotional disorders such as anxiety and depression | |
| Menezes et al. | Natural and synthetic flavonoids: structure–activity relationship and chemotherapeutic potential for the treatment of leukemia | |
| Merarchi et al. | Natural products and phytochemicals as potential anti‐SARS‐CoV‐2 drugs | |
| Chandra Pal et al. | Phytochemicals for the management of melanoma | |
| Gazak et al. | Silybin and silymarin-new and emerging applications in medicine | |
| Balaga et al. | Morin: a comprehensive review on its versatile biological activity and associated therapeutic potential in treating cancers | |
| EP3010498B1 (en) | Combination of cbd and cbg in the treatment of ovarian carcinoma | |
| El Abed et al. | Antioxidant, anti‐inflammatory, and antitumoral effects of aqueous ethanolic extract from Phoenix dactylifera L. parthenocarpic dates | |
| WO2009043395A3 (en) | Pharmaceutical composition | |
| CA2568997A1 (en) | Pharmaceutical compositions for the treatment of disease and/or symptoms in arthritis | |
| Mazurakova et al. | Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine—comprehensive effects of phytochemicals in primary, secondary and tertiary care | |
| EP2609928A3 (en) | Use of cannabinoids in combination with an anti-psychotic medicament | |
| F Nabavi et al. | Natural compounds used as therapies targeting to amyotrophic lateral sclerosis | |
| Ahmad et al. | A review on daidzein as food supplement: Exploring its phytopharmacological and preclinical status | |
| Bafandeh et al. | Natural Products as a Potential Source of Promising Therapeutics for COVID‐19 and Viral Diseases | |
| Obakan-Yerlikaya et al. | Breast cancer and flavonoids as treatment strategy | |
| Ul Hassan et al. | Isoflavones: Promising natural agent for cancer prevention and treatment | |
| Bonsignore et al. | Cancer therapy challenge: it is time to look in the “St. Patrick’s well” of the nature | |
| Pandey et al. | A mechanistic review of the pharmacological potential of narirutin: A dietary flavonoid | |
| WO2024108201A3 (en) | Cannabigerolic acid (cbga) and cannabigerol (cbg) derived products and methods of use |